Internal Medicine, Gastroenterology · Charlotte, NC
NPI
1922264654
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
1025 Morehead Medical Dr, Ste 300
Charlotte, NC, 28204
Phone (704) 355-4593
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
243 services
Medicare patients, 2024
164
Average age 70
Drug cost, 2024
$4.9M
1,013 prescriptions
Company payments, 2025
$155K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nilesh I Lodhia was code 99215 (office e&m - established), 68 times for 40 patients. In total Nilesh I Lodhia billed 243 services in 29 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 68 | 40 | $94.66 | $6,437 |
| 45385 Colonoscopy - Lesion Removal | Facility | 47 | 47 | $184.02 | $8,649 |
| 45380 Lower GI Endoscopy - Other | Facility | 24 | 24 | $91.06 | $2,185 |
| 43239 Upper GI Endoscopy | Facility | 18 | 18 | $63.64 | $1,146 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 14 | 14 | $159.69 | $2,236 |
By year: 2022 $40K for 336 services; 2023 $24K for 203 services; 2024 $29K for 243 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nilesh I Lodhia prescribed most often to Medicare patients was Omeprazole, with 101 prescriptions and refills. In total Nilesh I Lodhia wrote 1,013 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 101 | 282 | 35 | $2,274 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 92 | 92 | 87 | $6,064 |
| Stelara Ustekinumab | 83 | 83 | Under 11 | $2.2M |
| Humira(Cf) Pen Adalimumab | 63 | 63 | Under 11 | $922K |
| Skyrizi On-Body Risankizumab-Rzaa | 61 | 79 | Under 11 | $1.2M |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 57 | 57 | 55 | $877 |
| Diphenhydramine Hcl Generic | 51 | 51 | Under 11 | $736 |
| Pantoprazole Sodium Generic | 47 | 111 | 14 | $802 |
| Rinvoq Upadacitinib | 40 | 40 | Under 11 | $379K |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 37 | 37 | 34 | $4,617 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 29 | 29 | Under 11 | $513 |
| Linzess Linaclotide | 21 | 41 | Under 11 | $21K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 18 | 18 | 17 | $318 |
| Promethazine Hcl Generic | 16 | 26 | Under 11 | $429 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 15 | 15 | 15 | $2,058 |
Brand drugs: 460 claims; generic drugs: 553 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nilesh I Lodhia $155K ($155K in general payments such as food, travel and fees) from 15 companies. The largest payer was Janssen Biotech, Inc. with $85K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 74 | $85K |
| Abbvie Inc. ABBV | 60 | $33K |
| Celltrion USA Inc. 068270.KS | 43 | $25K |
| Pfizer Inc. PFE | 27 | $11K |
| Lilly USA, LLC LLY | 6 | $331 |
| Cook Medical LLC | 1 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $114 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $47.82 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $47.7 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $23.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.